Skip to main content

Diabetes Ketosis Sensor Tester App ADC-US-RES-24259

Status: Open to Enrollment
Email Us To Enroll

Study Details

View study details on clinicaltrials.gov.

Locations

  • Burlingame

Clinical Trial FAQs

Information for patients and study volunteers, including frequently asked questions.

A minimum of 30 evaluable participants are required per subgroup (10 subgroups identified). A minimum of 100 evaluable participants aged ≥65 years will be included. A minimum of 100 evaluable participants aged 2-17 years will be included. Up to approximately 1600 participants will be enrolled to attain a minimum of 800 evaluable participants. An evaluable participant is a participant with 180 hours (nominally 50%) ketone reading data capture.

Approximately 16 days per participant; total anticipated maximum duration of 46 days per participant.

Diagnosis of either type 1 or type 2 diabetes mellitus, or heart failure, or gestational diabetes mellitus.

David Klonoff
David Klonoff
Principal investigator
View Profile

Email Us to Enroll

You're leaving our site

The website you have selected is an external one located on another server. This website may contain links to third party sites. These links are provided for convenience purposes and are not under the control of Sutter Health. Do you wish to continue?